Pular para o conteúdo
Merck
Todas as fotos(2)

Key Documents

View All Documentation

677418

Sigma-Aldrich

Fosfato de cálcio

nanopowder, <200 nm particle size (BET), ≥97%, synthetic

Sinônimo(s):

Fosfato de cálcio tribásico, HAp, Hidroxifosfato de cálcio, Hidroxilapatita

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(2)

About This Item

Fórmula linear:
[Ca5(OH)(PO4)3]x
Número CAS:
12167-74-7
Peso molecular:
502.31
Número CE:
235-330-6
Número MDL:
MFCD00010904
Código UNSPSC:
12352302
ID de substância PubChem:
24885371
NACRES:
NA.23

Nível de qualidade

100

Ensaio

≥97%

forma

nanopowder
solid

área da superfície

>9.4 m2/g

tamanho de partícula

<200 nm (BET)

pf

1100 °C (lit.)

cadeia de caracteres SMILES

[Ca++].[Ca++].[Ca++].[Ca++].O[Ca+].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O

InChI

1S/5Ca.3H3O4P.H2O/c;;;;;3*1-5(2,3)4;/h;;;;;3*(H3,1,2,3,4);1H2/q5*+2;;;;/p-10

chave InChI

XYJRXVWERLGGKC-UHFFFAOYSA-D

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

Hydroxyapatite(HA) belongs to the family of Ca apatite which resembles natural bone in both structure and chemical composition. It can be prepared by various techniques such as chemical precipitation, hydrothermal, electrospinning, and self-propagating combustion. It is widely used as an implant material for bone regeneration, a drug carrier, and a gene delivery system due to its bioactive and biocompatible nature.

Aplicação

Nanoscale hydroxyapatite particles can be used to prepare bone tissue engineering materials due to their slow biodegradability in situ, good osteoconductive and osteoinductive capabilities.

Poly (sodium 4-styrene sulfonate)-modified hydroxyapatite nanoparticles can be used as a drug carrier for vancomycin. Hydroxyapatite nanoparticles control the release of antibiotics after the implantation of a scaffold in the body.

Porous hydroxyapatite microspheres exhibit a high adsorptive capacity for heavy metals and can be used for the treatment of heavy metal contaminated water.

Características e benefícios

  • Bioactive and biocompatible
  • Good mechanical strength
  • Porous structure
  • Osteoconductive and osteointegrative properties

Informações legais

Product of Engi-Mat Co.

Código de classe de armazenamento

13 - Non Combustible Solids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Equipamento de proteção individual

dust mask type N95 (US), Eyeshields, Gloves

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number
MKCQ2685
MKCN9004
MKCM1889
MKCK9555
MKCK8172

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Pesquise por COA

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 7

1 of 7

Calcium phosphate, amorphous nanopowder, &lt;150&#160;nm particle size (BET)

Sigma-Aldrich

693871

Calcium phosphate, amorphous

Hydroxyapatite purum p.a., &#8805;90% (as Ca3(PO4)2, KT)

Sigma-Aldrich

21223

Hydroxyapatite

Hydroxyapatite Type I, buffered aqueous suspension

Sigma-Aldrich

H0252

Hydroxyapatite

Tricalcium phosphate hydrate nanopowder, &lt;200&#160;nm particle size (BET)

Sigma-Aldrich

693898

Tricalcium phosphate hydrate

3D Printing Hydroxyapatite ink

Sigma-Aldrich

902403

3D Printing Hydroxyapatite ink

&#946;-tri-Calcium phosphate puriss. p.a., &#8805;98% &#946;-phase basis (sintered Powder)

Sigma-Aldrich

49963

β-tri-Calcium phosphate

&#946;-tri-Calcium phosphate puriss. p.a., &#8805;98% &#946;-phase basis (unsintered powder)

Sigma-Aldrich

13204

β-tri-Calcium phosphate

Sang-Soo Kim et al.
Biomaterials, 27(8), 1399-1409 (2005-09-20)
Biodegradable polymer/bioceramic composite scaffolds can overcome the limitations of conventional ceramic bone substitutes such as brittleness and difficulty in shaping. However, conventional methods for fabricating polymer/bioceramic composite scaffolds often use organic solvents (e.g., the solvent casting and particulate leaching (SC/PL)
Michiko Sato et al.
Biomaterials, 27(11), 2358-2369 (2005-12-13)
In order to improve orthopedic implant performance, the objective of this in vitro study was to synthesize nanocrystalline hydroxyapatite (HA) powders to coat titanium. HA was synthesized through a wet chemical process. The precipitated powders were either sintered at 1100
Influence of temperature, ripening time and calcination on the morphology and crystallinity of hydroxyapatite nanoparticles.
Pang YX, et al.
J. Eur. Ceram. Soc., 23(10), 1697-1704 (2003)
Hydroxyapatite nanoparticles: a review of preparation methodologies
Ferraz MP, et al.
Journal of Applied Biomaterials & Biomechanics : JABB, 2(2), 74-80 (2004)
Liam M Grover et al.
Biomaterials, 34(28), 6631-6637 (2013-06-12)
Pyrophosphate ions are both inhibitors of HA formation and substrates for phosphatase enzymes. Unlike polyphosphates their hydrolysis results simultaneously in the complete loss of mineral formation inhibition and a localised elevation in orthophosphate ion concentration. Despite recent advances in our
Exibir todos os documentos relacionados

Artigos

Nanomaterials for Biomedical Applications

Dendrimers are just one class of nano-sized materials that are explored to develop new life-saving technologies. Single-wall carbon nanotubes are used to make miniaturized sensors for DNA, pathogens, and chemicals – for example glucose sensors. Multi-wall nanotubes, nanoclays, and ceramic nanoparticles are incorporated in ultra-strong polymer nanocomposites that will be used in orthopedic, for example joint-replacement, applications.

Innovative Materials for Glass Ionomer Cements (GICs): Dental Applications

Innovation in dental restorative materials is driven by the need for biocompatible and natural-appearing restoration alternatives. Conventional dental materials like amalgam and composite resins have inherent disadvantages.

Strategy for Toxicity Screening of Nanomaterials

A key challenge for nanomaterial safety assessment is the ability to handle the large number of newly engineered nanomaterials (ENMs), including developing cost-effective methods that can be used for hazard screening.

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica